Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SRL-172 shows promising initial results in phase I/II asthma trial

Aug. 20, 1999

Discovery receives Cystic Fibrosis Foundation grant for SuperVent

Aug. 20, 1999

Cell adhesion inhibitor series has potential application in inflammatory and immune disorders

Aug. 18, 1999

Immune Network Research forms JV with Bridge Pharma to develop asthma drug

Aug. 18, 1999

Antiinflammatory effects of TxA2 antagonist confirmed in patients with asthma

Aug. 13, 1999

Dual-action antihistamines/substance P antagonists from HMR

Aug. 12, 1999

Bayer will begin clinical trials of IL-4 antagonist for asthma

Aug. 12, 1999

Bayer reveals antiinflammatory PDE4 inhibitors in patent literature

Aug. 10, 1999

Medeva acquires additional European rights to ML Laboratories' MDPI device

Aug. 10, 1999

Novel PAF antagonist CPR-3005 claimed in patent literature by Clarion

Aug. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...